Abstract
Background and objective Observational studies suggest that dietary sodium (salt) intake may be associated with body mass index (BMI). However, these findings may be biased by confounding and reverse causality. The present study aimed to apply a bidirectional Mendelian Randomization (MR) framework to determine the causal association between salt added to food (do not include salt used in cooking) and BMI by integrating summary-level genome-wide association study (GWAS) data.
Methods We performed two-sample MR analyses using summary statistics of GWAS. Inverse-variance weighted (IVW) method was used to analyze the effect of the preference of salt added to food on BMI. We used maximum likelihood estimation and random effect model as auxiliary verification. A bidirectional MR analysis with BMI as the exposure and salt added to food as the outcome was also performed.
Results We identified 74 single nucleotide polymorphisms (SNPs) that were genome-wide significant (P < 5×10-8) for the preference of salt added to food in the UK Biobank (n = 462,630) and were investigated for their association with BMI in a meta-analysis of 322,154 European-descent individuals from GWAS and Metabochip studies. The IVW method estimate indicated that the preference of salt added to food was positively associated with BMI (β = 0.1416, SE = 0.0576, P = 0.0139). Results from maximum likelihood estimation (β = 0.1476, SE = 0.0363, P < 0.0001) and the random effect model (β = 0.1411, SE = 0.0572, P = 0.0137) were consistent with the IVW. Bidirectional MR analyses suggested that BMI was not associated with the preference of salt added to food.
Conclusion Our results provided qualitative evidence supporting a causal relationship between salt intake and BMI.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was not specifically funded.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All GWASs have existing ethical permissions from their respective institutional review boards and include participant informed consent.UK Biobank received ethics approval from the National Health Service National Research Ethics Service and participants provided written informed consent.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data was publicly available through https://gwas.mrcieu.ac.uk/
